Alamar Biosciences, Inc. (California) (ALMR)
30.49
-0.22
(-0.72%)
USD |
NASDAQ |
Aug 31, 16:00
30.87
+0.38
(+1.25%)
After-Hours: 20:00
Alamar Biosciences Cash from Operations (Annual) : -53.61M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -53.61M |
| Date | Value |
|---|---|
| December 31, 2024 | -55.21M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| 10X Genomics, Inc. | 136.05M |
| Personalis, Inc. | -74.95M |
| Twist Bioscience Corp. | -47.63M |
| Adaptive Biotechnologies Corp. | -45.99M |
| Champions Oncology, Inc. | -4.472M |